Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Prostatic Neoplasms 120Lymphoma 90Lymphoma, Large B-Cell, Diffuse 79Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Burkitt Lymphoma 31Multiple Myeloma 26Lymphoma, Non-Hodgkin 26Lymphoma, Follicular 26Leukemia 26Hodgkin Disease 24Lymphoma, Mantle-Cell 18Neoplasms 16Lymphoma, T-Cell, Peripheral 16Lymphoma, B-Cell 14Lymphoma, Large-Cell, Immunoblastic 12Lymphoma, Large-Cell, Anaplastic 11Dendritic Cell Sarcoma, Interdigitating 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Recurrence 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Lymphocytic, Chronic, B-Cell 8Neoplasms, Plasma Cell 7Neoplasm Metastasis 7Waldenstrom Macroglobulinemia 6Primary Myelofibrosis 6Lymphoma, T-Cell 6Immunoblastic Lymphadenopathy 6HIV Infections 5Graft vs Host Disease 5Blast Crisis 5

Interventions

Cyclophosphamide 7fludarabine phosphate 4Tacrolimus 4Mycophenolic Acid 4Busulfan 4pembrolizumab 2fludarabine 2cobomarsen 2Whole-Body Irradiation 2Vincristine 2Rituximab 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mesna 2Melphalan 2Doxorubicin 2thymoglobulin 1Vorinostat 1Plasmalyte A 1Ifosfamide 1Etoposide 1Dimethyl Sulfoxide 1Carboplatin 1Brentuximab Vedotin 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Immune System Diseases × Prednisone × Clear all
NCT02855359 2019-03-11

Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

Seagen Inc.

Phase 2 Terminated
24 enrolled 10 charts
Lymphoid

Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00365274 2014-06-02

SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma

National Cancer Institute (NCI)

Phase 2 Terminated
6 enrolled 3 charts
Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡